spacer
home > epc > spring 2009 > competing with big pharma
PUBLICATIONS
European Pharmaceutical Contractor

Competing with Big Pharma

Good ideas for new drugs can come from anywhere. There was a time – now it seems like ancient history – when virtually all ideas came from the R&D departments of large pharmaceutical companies. Today, they often come from research carried out by dedicated groups of scientists at universities and small and medium-sized biotech firms, or even ‘virtual’ research groups connected by the internet.

Regardless of how it’s achieved, coming up with a concept for a new drug is not a random event. It starts with deciding what questions to ask in order to identify potential targets for a disease, and later focuses on developing strategies to find effective candidates that selectively affect those targets. Through hard work and trial and error, thousands of labs across the UK are developing new candidates every day. Thankfully, with some regularity, one scientist will turn to his or her colleagues and say, “I think we’ve got something here.” Then what?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Mark Crane joined Ricerca as Vice President, Business Development and Marketing in June 2007. Mark has overseen the development of the new Ricerca ‘IP to IND’ brand, as well as the development of the website and sales literature. Prior to joining Ricerca, Mark served as Vice President, Sales and Marketing, for both Bridge Global Pharmaceutical Services and Quest Pharmaceutical Services. Mark was also a Vice President, of Global Business Development, Preclinical/Discovery Services for MDS Pharmaceutical Services, and held various posts at MDS Panlabs, AVANTEC, Inc and the Perkin Elmer Corporation. He holds a BS degree in Health Education/Community Health from Western Connecticut State University at Danbury.

spacer
Mark Crane
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Wool packaging firm’s green scheme goes ‘beyond recycling’

An award-winning company that has spent more than 10 years innovating in sustainable packaging has launched a scheme that it says goes ‘beyond recycling’ – by allowing the end user to return their packaging directly to them to be used again.
More info >>

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement